Maternal Combination Antiretroviral Therapy Is Associated with Improved Retention of HIV-Exposed Infants in Kinshasa, Democratic Republic of Congo

Journal of Acquired Immune Deficiency Syndromes

Volumn 69, Issue 3, 2015, Pages e93-e99

  Feinstein, Lydia ^a   Edmonds, Andrew ^a   Okitolonda, Vitus ^b   Cole, Stephen R ^a   Rie, Annelies Van ^a   Chi, Benjamin H ^c   Ndjibu, Papy ^b   Lusiama, Jean ^b   Chalachala, Jean L ^b   Behets, Frieda ^a  

^a University of North Carolina at Chapel Hill   (United States)

^b UNIVERSITY OF KINSHASA   (Congo)

^c UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

Democratic Republic of Congo; HIV exposed infants; loss to follow up; pediatric HIV; prevention of mother to child HIV transmission; retention in care

Indexed keywords

ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT;

ADULT; ANTIVIRAL THERAPY; ARTICLE; COHORT ANALYSIS; CONGO; FEMALE; FOLLOW UP; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN IMMUNODEFICIENCY VIRUS PREVALENCE; INCIDENCE; INFANT; MAJOR CLINICAL STUDY; MALE; PRENATAL CARE; PRIORITY JOURNAL; VERTICAL TRANSMISSION; CD4 LYMPHOCYTE COUNT; DEMOCRATIC REPUBLIC CONGO; DRUG COMBINATION; HIV INFECTIONS; NEWBORN; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; PREVENTION AND CONTROL; TRANSMISSION;

ADULT; ANTI-HIV AGENTS; CD4 LYMPHOCYTE COUNT; COHORT STUDIES; DEMOCRATIC REPUBLIC OF THE CONGO; DRUG THERAPY, COMBINATION; FEMALE; HIV INFECTIONS; HUMANS; INCIDENCE; INFANT, NEWBORN; INFECTIOUS DISEASE TRANSMISSION, VERTICAL; LOST TO FOLLOW-UP; MALE; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS;

EID: 84933056397     PISSN: 15254135     EISSN: 10779450     Source Type: Journal    
DOI: 10.1097/QAI.0000000000000644     Document Type: Article

References (32)

1. The Joint United Nations Programme on HIV/AIDS (UNAIDS). Global Report: UNAIDS Report on the Global AIDS Epidemic 2013. UNAIDS, Geneva, Switzerland; 2013.
2. Sibanda E, Weller I, Hakim J, et al. The magnitude of loss to follow-up of HIV-exposed infants along the prevention of mother-to-child HIV transmission continuum of care: a systematic review and meta-analysis. AIDS. 2013;27:2787-2797.
3. World Health Organization (WHO). PMTCT Strategic Vision 2010-2015: Preventing Mother-to-child Transmission of HIV to Reach the UNGASS and Millennium Development Goals: Moving Towards the Elimination of Paediatric HIV. World Health Organization, Geneva, Switzerland; 2010.
4. Barker PM, Mphatswe W, Rollins N. Antiretroviral drugs in the cupboard are not enough: the impact of health systems' performance on mother-to-child transmission of HIV. J Acquir Immune Defic Syndr. 2011;56:e45-e48.
5. Violari A, Cotton MF, Gibb DM, et al. Early antiretroviral therapy and mortality among HIV-infected infants. N Engl J Med. 2008;359: 2233-2244.
6. World Health Organization (WHO). Antiretroviral Therapy of HIV Infection in Infants and Children: Towards Universal Access: Recommendations for a Public Health Approach (2010 Revision). World Health Organization, Geneva, Switzerland; 2010.
7. Clouse K, Pettifor A, Maskew M, et al. Initiating antiretroviral therapy when presenting with higher CD4 cell counts results in reduced loss to follow-up in a resource-limited setting. AIDS. 2013;27:645-650.
8. Behets F, Edmonds A, Kitenge F, et al. Heterogeneous and decreasing HIV prevalence among women seeking antenatal care in Kinshasa, Democratic Republic of Congo. Int J Epidemiol. 2010;39:1066-1073.
9. Edmonds A, Yotebieng M, Lusiama J, et al. The effect of highly active antiretroviral therapy on the survival of HIV-infected children in a resource-deprived setting: a cohort study. PLoS Med. 2011;8:e1001044-e1001044.
10. Edmonds A, Yotebieng M, Lusiama J, et al. Quantification of CD4 responses to combined antiretroviral therapy over 5 years among HIV-infected children in Kinshasa, Democratic Republic of Congo. J Acquir Immune Defic Syndr. 2012;61:90-98.
11. Feinstein L, Edmonds A, Chalachala JL, et al. Temporal changes in the outcomes of HIV-exposed infants in Kinshasa, Democratic Republic of Congo during a period of rapidly evolving guidelines for care (2007-2013). AIDS. 2014;28(suppl 3):S301-S311.
12. Chi BH, Yiannoutsos CT, Westfall AO, et al. Universal definition of loss to follow-up in HIV treatment programs: a statistical analysis of 111 facilities in Africa, Asia, and Latin America. PLoS Med. 2011;8:e1001111-e1001111.
13. World Health Organization (WHO). Antiretroviral Drugs for Treating Pregnant Women and Preventing HIV Infenction in Infants: Towards Universal Access: Recommendations for a Public Health Approach (2006 Version). World Health Organization, Geneva, Switzerland; 2006.
14. World Health Organization (WHO). Antiretroviral Drugs for Treating Pregnant Women and Preventing HIV Infection in Infants: Recommendations for a Public Health Approach (2010 Version). World Health Organization, Geneva, Switzerland; 2010.
15. WHO Multicentre Growth Reference Study Group. WHO Child Growth Standards: Length/height-for-age, Weight-for-age, Weight-for-length, Weight-for-height and Body Mass Index-for-age: Methods and Development. World Health Organization, Geneva, Switzerland; 2006.
16. Lau B, Cole SR, Gange SJ. Competing risk regression models for epidemiologic data. Am J Epidemiol. 2009;170:244-256.
17. Kohl M, Plischke M, Leffondre K, Heinze G. PSHREG: a SAS macro for proportional and nonproportional subdistribution hazards regression. Computer Methods and Programs in Biomedicine. 2015;118(2): 218-233.
18. Fine JP, Gray RJ. A proportional hazards model for the subdistribution of a competing risk. J Am Stat Assoc. 1999;94:496-509.
19. Stone C, Koo C. Y. Additive splines in statistics. In Proceedings of the Statistical Computing Section, Amer. Statist. Assoc., Washington, DC; 1986:45-48.
20. Raghunathan TE, Lepkowski JM, Hoewyk JV, Solenberger P. A Multivariate Technique for Multiply Imputing Missing Values Using a Sequence of Regression Models. Survey Methodology. 2001;27(1): 85-95.
21. Klebanoff MA, Cole SR. Use of multiple imputation in the epidemiologic literature. Am J Epidemiol. 2008;168:355-357.
22. Cook RE, Ciampa PJ, Sidat M, et al. Predictors of successful early infant diagnosis of HIV in a rural district hospital in Zambezia, Mozambique. J Acquir Immune Defic Syndr. 2011;56:e104-e109.
23. Tejiokem MC, Faye A, Penda IC, et al. Feasibility of early infant diagnosis of HIV in resource-limited settings: the ANRS 12140-PEDIACAM study in Cameroon. PLoS One. 2011;6:e21840-e21840.
24. World Health Organization (WHO). WHO Recommendations on the Diagnosis of HIV Infection in Infants and Children. World Health Organization, Geneva, Switzerland; 2010.
25. Van Cutsem G, Ford N, Hildebrand K, et al. Correcting for mortality among patients lost to follow up on antiretroviral therapy in South Africa: a cohort analysis. PLoS One. 2011;6:e14684.
26. Jones SA, Sherman GG, Varga CA. Exploring socio-economic conditions and poor follow-up rates of HIV-exposed infants in Johannes-burg, South Africa. AIDS Care. 2005;17:466-470.
27. Kiragu K, Schenk K, Murugi J, et al. "If You Build it, Will They Come?"Kenya Healthy Start Pediatric HIV Study: A Diagnostic Study Investigating Barriers to HIV Treatment and Care Among Children. Horizons Final Report. Washington, DC: Population Council; 2008.
28. Painter TM, Diaby KL, Matia DM, et al. Women's reasons for not participating in follow up visits before starting short course antiretroviral prophylaxis for prevention of mother to child transmission of HIV: qualitative interview study. BMJ. 2004;329:543-543.
29. Panditrao M, Darak S, Kulkarni V, et al. Socio-demographic factors associated with loss to follow-up of HIV-infected women attending a private sector PMTCT program in Maharashtra, India. AIDS Care. 2011;23:593-600.
30. Ciampa PJ, Tique JA, Juma N, et al. Addressing poor retention of infants exposed to HIV: a quality improvement study in rural Mozambique. J Acquir Immune Defic Syndr. 2012;60:e46-e52.
31. Donahue MC, Dube Q, Dow A, et al. "They have already thrown away their chicken": barriers affecting participation by HIV-infected women in care and treatment programs for their infants in Blantyre, Malawi. AIDS Care. 2012;24:1233-1239.
32. World Health Organization (WHO). Consolidated Guidelines on the Use of Antiretroviral Drugs for Treating and Preventing HIV Infection: Recommendations for a Public Health Approach (June 2013). World Health Organization, Geneva, Switzerland; 2013.